AF Ablation Procedures Driving CRM Market Expansion

Cardiac rhythm management device sales in the US are projected to grow at a compound annual rate of 2.9%, increasing to an estimated $8.2 billion in the year 2019. Two of the fastest growing sectors of the market, electrophysiology and ablation devices, will be driven by a 10% to 20% growth in the number of patients treated for atrial fibrillation.

The US market for cardiac rhythm management (CRM) devices is expected to grow by approximately $1.1 billion at a compound annual growth rate (CAGR) of 2.9% over the next five years; diagnostic CRM products are forecast to grow at a CAGR of 4.8%, while therapeutic CRM products will grow at a CAGR of 2.7%.

Two of the fastest growing areas of the CRM products market, electrophysiology (EP) and cardiac ablation devices, are being driven by an expansion in the use of ablation techniques to...

More from Surgical Procedures

More from Surgery